Medical research is not defensible merely because the final manuscript is well written or the reported p-value is below 0.05. A result becomes defensible when another qualified person can trace how the research question became a protocol, how the data were transformed, why the analysis was appropriate, and where uncertainty remains.
This is where medical research and data science must operate as one discipline. Statistical software can generate a result in seconds, but it cannot repair an unclear study question, biased sampling, undocumented data cleaning, inappropriate modeling, or unsupported interpretation. Reliable research therefore depends on controls that begin before analysis and continue after the manuscript is drafted.
01Define the research question before selecting the statistical test
A common mistake is to start with the available spreadsheet and ask, “What analysis can we run?” The better sequence begins with the clinical or public-health question.
The research team should first define the population, exposure or intervention, comparator, outcome, and relevant time frame. It should then identify the study design and the quantity the analysis is intended to estimate. Only after these decisions should the team choose statistical methods.
This order matters because the same variables may require different analyses depending on the scientific question. A model intended to explain an association is not automatically appropriate for prediction. A risk-prediction model is not automatically evidence of causation. A statistically significant association is not automatically clinically important.
02Treat data provenance as part of the scientific method
Every analytical variable should have a traceable origin. Researchers should know where the data came from, who collected them, what each field means, how missing values are represented, and what transformations occurred before analysis.
A minimum data package should include:
- A data dictionary with variable definitions, coding, units, and permissible values
- A record of inclusion and exclusion decisions
- Documented rules for outliers, duplicates, and missing observations
- A transformation log showing how raw variables became analytical variables
- Version identifiers for the dataset and analysis code
These are not administrative extras. They protect the study from silent errors. For example, an undocumented change from milligrams to grams, an inverted binary code, or an unrecognized duplicate patient can materially change a result while leaving the final table looking professionally formatted.
The United States National Institutes of Health emphasizes that good data-management practices form the foundation of reliable and reproducible findings. Its Data Management and Sharing Policy also highlights prospective planning, appropriate sharing, and protection of participant privacy.
03Separate data cleaning from statistical analysis
When cleaning decisions and hypothesis testing occur inside the same unstructured workflow, researchers may unintentionally make the data conform to an expected result. A more defensible process separates the stages.
First, define validation rules and produce a data-quality report. Second, resolve or document anomalies without looking for the most favorable inferential result. Third, lock the analysis-ready dataset or record its version. Finally, execute the prespecified analysis plan.
Not every medical study can follow a perfectly fixed plan. Unexpected data problems occur, and exploratory analysis is scientifically valuable. The safeguard is transparency: distinguish prespecified analyses from post hoc or exploratory analyses, explain why changes were made, and avoid presenting data-driven decisions as if they had been planned from the beginning.
04Make the analysis reproducible
A defensible analysis should not depend on a sequence of undocumented mouse clicks. Whenever possible, researchers should use code or a recorded syntax file that can recreate the main tables, figures, and model outputs from a defined analytical dataset.
Reproducibility does not necessarily require making sensitive clinical data public. Human-participant information must remain protected according to consent, ethics approval, institutional policy, and applicable privacy law. Reproducibility can instead be supported through controlled access, de-identified or synthetic demonstration data, documented metadata, analysis scripts, software-version records, and a clear computational environment.
The practical test is simple: could another qualified analyst understand what was done and reproduce the reported output without guessing?
05Report uncertainty, not just statistical significance
Medical research decisions are rarely well served by a binary “significant” or “not significant” conclusion. Researchers should report effect estimates, confidence intervals, relevant absolute measures, model assumptions, missing-data implications, and limitations arising from design or measurement.
A narrow p-value-focused interpretation can hide important questions:
- Is the effect large enough to matter clinically?
- Is the confidence interval compatible with meaningful benefit and harm?
- Were multiple comparisons performed?
- Does the sample represent the population to which the conclusion is being applied?
- Could confounding, selection bias, or measurement error explain the finding?
- Was the model evaluated for calibration, discrimination, or overfitting where appropriate?
Good scientific communication makes uncertainty visible. It does not weaken the research; it shows that the research team understands the boundaries of its evidence.
06Keep human accountability when using artificial intelligence
Artificial intelligence can help organize literature, review code, suggest data checks, improve clarity, or identify inconsistencies. It must not become an invisible substitute for scientific judgment.
The World Health Organization recommends that AI for health protect human autonomy, safety, transparency, accountability, privacy, and equity. The International Committee of Medical Journal Editors similarly states that humans remain responsible for the accuracy, integrity, originality, and appropriate disclosure of work produced with AI assistance.
For medical research teams, this means verifying every citation, independently reviewing analytical code, checking generated text against source evidence, documenting material AI use, and never entering identifiable or confidential patient information into an unauthorized system. AI may accelerate a controlled workflow, but it cannot accept responsibility for an incorrect conclusion.
Defensibility is a team standard
The strongest research teams do more than produce outputs. They maintain a chain of reasoning that connects the clinical question, protocol, data, analysis, interpretation, and final communication.
That chain is the real product of rigorous medical research. It enables researchers to answer advisers, ethics committees, peer reviewers, institutional leaders, and—most importantly—the patients and communities whose information made the research possible.
References
- National Institutes of Health. Data Management and Sharing Policy Overview. ↗ Accessed 26 July 2026.
- World Health Organization. Ethics and governance of artificial intelligence for health. 2021. ↗ Accessed 26 July 2026.
- World Health Organization. Ethics and governance of artificial intelligence for health: guidance on large multi-modal models. 2024. ↗ Accessed 26 July 2026.
- International Committee of Medical Journal Editors. Defining the Role of Authors and Contributors. ↗ Accessed 26 July 2026.
This article is for research education and does not provide individual medical advice. No patient data were used.
